{
    "title": "Individual feed for http://feeds.benzinga.com/benzinga",
    "link": "http://feeds.benzinga.com/benzinga",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-08-15T11:04:06.798961",
    "items": [
        {
            "title": "Dow Surges Over 200 Points; Flowers Foods Shares Fall After Q2 Results",
            "link": "https://www.benzinga.com/markets/market-summary/25/08/47155334/dow-surges-over-200-points-flowers-foods-shares-fall-after-q2-results",
            "description": "read more",
            "pubDate": "2025-08-15T14:58:20",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/08/15/Portland--Or--Usa---Mar-12--2020-Dow-Jon.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Tiger Global Boosts Big Tech Bets, Ramps Up Portfolio Value By 28% In Q2",
            "link": "https://www.benzinga.com/markets/hedge-funds/25/08/47155182/tiger-global-boosts-big-tech-bets-ramps-up-portfolio-value-by-28-in-q2",
            "description": "Chase Coleman's Tiger Global boosted its portfolio value and reshuffled key holdings in Q2 2025. The firm is known for its aggressive, research-driven...",
            "pubDate": "2025-08-15T14:53:27",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/08/15/Binary-Options-Chart.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Why Is Precigen Stock Surging On Friday?",
            "link": "https://www.benzinga.com/news/fda/25/08/47154782/why-is-precigen-stock-surging-on-friday",
            "description": "Precigen's Papzimeos wins FDA approval as the first therapy for adult recurrent respiratory papillomatosis, showing durable results in clinical trials...",
            "pubDate": "2025-08-15T14:48:12",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/08/15/Medical-research.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Intel Jumps As Trump Explores Investment In Bid To Revive US Chip Ambitions",
            "link": "https://www.benzinga.com/trading-ideas/movers/25/08/47154632/intel-jumps-as-trump-explores-investment-in-bid-to-revive-us-chip-ambitions",
            "description": "Intel stock gains after report of potential government stake, amid weak balance sheet and delays. Trump's softened stance and CEO meeting. read more",
            "pubDate": "2025-08-15T14:45:19",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/08/15/Santa-Clara--Ca--Usa---Nov-22--2023-Inte.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "XRP Down 6% In 1 Week As ETH Keeps Pumping: What Is Going On?",
            "link": "https://www.benzinga.com/crypto/cryptocurrency/25/08/47154180/xrp-down-6-in-1-week-as-eth-keeps-pumping-what-is-going-on",
            "description": "XRP (CRYPTO: XRP ) is down 6% over the past week, but traders remain upbeat about the tokenâ€™s near-term prospects . read more",
            "pubDate": "2025-08-15T14:38:03",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/08/15/XRP-Ripple.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        }
    ]
}